ULBI: 26% | Ultralife shares are trading higher after the company reported better-than-expected Q1 financial results.

CDTX: 41% | Cidara Therapeutics shares are trading higher after the company announced the divestiture of rezafungin to Mundipharma, reacquired global development and commercial rights to CD388 and announced $240 million in private placement financing.

OPTN: 36% | Optinose Provides Corporate Updates; Expects To Produce Positive Income From Operations For Full Year 2025